Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Clinical Trial ID NCT01955499

PubWeight™ 2.29^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01955499

Top papers